Meanwhile, they found that HMGB1-binding heptamer peptide (HBHP) treatment significantly down-regulated protein expression of delayed tPA-treated rat cerebral ischemia hemisphere-inducible nitric oxide synthase, COX-2, and IL-1β, which was beneficial in attenuating neurovascular complications [160]. The gene discussed is HMGB1; the disease is brain ischemia.